Breaking News Bar

Business News and Information

Lilly’s COVID-19 treatment receives emergency-use approval from FDA, stock jumps 3%

Eli Lilly & Co.'s COVID-19 antibody treatment was approved for emergency use by the Food and Drug Administration on Monday, and Lilly shares jumped more than 3% in after-hours trading.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear